Back to discover
Disease
Gender Dysphoria
Late-stage therapeutic developmentEmerging research
2
Publications
12
Clinical trials
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2024-10-30Archives of disease in childhood
Research2017-11-01The Journal of clinical endocrinology and metabolism
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q3 2026.
Major developments
Major trial resultsHigh impact
Results posted2026-02-12
Upcoming trial readoutImportant
Results expected Q3 20262025-09-17
Clinical MilestonesViewHide
Results posted
- 2026-02-12Counseling Among Gender Diverse Adolescents Who Use Depot MedroxyprogesteroneResults posted
Results expected
Recently completed
- 2025-12-30Early Mental Response to Hormonal Treatment in Transgender Men - The EMRE StudyPrimary completion
Activity timeline3
- 2026-02-12ClinicalCounseling Among Gender Diverse Adolescents Who Use Depot MedroxyprogesteroneResults posted
- 2025-12-30ClinicalEarly Mental Response to Hormonal Treatment in Transgender Men - The EMRE StudyPrimary completion
- 2025-09-17ClinicalDevelopment of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming SurgeriesResults expected Q3 2026
Clinical trials
The current development programme across all trial phases.
Clinical programme
12
4
6
5
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20172024
Most influential
Major themes1
- Gender Dysphoria1
Leading journals2
- Archives of disease in childhood1
- The Journal of clinical endocrinology and metabolism1
Leading researchers8
- Cohen-Kettenis PT1
- Fraser L1
- Gooren L1
- Hall R1
- Hannema SE1
- Hembree WC1
- Hewitt CE1
- Langton T1
Affiliations (unnormalised)6
- Boston University School of Medicine1
- Emory University School of Medicine and the Atlanta VA Medical Center1
- Ghent University Hospital1
- Leiden University Medical Center1
- Mayo Clinic Evidence-Based Practice Center1
- New York Presbyterian Hospital1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A marked difference between the individual’s expressed/experienced gender and the gender others would assign to the individual, and it must continue for at least six months. (from DSM-5)
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.